DMB-3115

· Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DMB-3115, covering 2024-01-18 to 2024-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

See pricing